Interleukin-6 stimulates lipolysis and fat oxidation in humans

van Hall, G, Steensberg, A, Sacchetti, M, Fischer, C, Keller, C, Schjerling, P, Hiscock, N, Moller, K, Saltin, B, Febbraio, M and Pedersen, B 2003, 'Interleukin-6 stimulates lipolysis and fat oxidation in humans', Journal of Clinical Endocrinology and Metabolism, vol. 88, no. 7, pp. 3005-3010.


Document type: Journal Article
Collection: Journal Articles

Title Interleukin-6 stimulates lipolysis and fat oxidation in humans
Author(s) van Hall, G
Steensberg, A
Sacchetti, M
Fischer, C
Keller, C
Schjerling, P
Hiscock, N
Moller, K
Saltin, B
Febbraio, M
Pedersen, B
Year 2003
Journal name Journal of Clinical Endocrinology and Metabolism
Volume number 88
Issue number 7
Start page 3005
End page 3010
Total pages 6
Publisher Endocrine Society
Abstract Although IL-6 is a key modulator of immune function, it also plays a role in regulating substrate metabolism. To determine whether IL-6 affects lipid metabolism, 18 healthy men were infused for 3 h with saline (Con; n = 6) or a high dose (High-rhIL6; n = 6) or a low dose (Low-rhIL6; n = 6) of recombinant human IL-6 (rhIL-6). The IL-6 concentration during Con, Low-rhIL6, and High-rhIL6 was at a steady state after 30 min of infusion at approximately 4, 140, and 320 pg/ml, respectively. Either dose of rhIL-6 was associated with a similar increase in fatty acid (FA) concentration and endogenous FA rate of appearance (Ra) from 90 min after the start of the infusion. The FA concentration and FA Ra continued to increase until the cessation of rhIL-6 infusion, reaching levels approximately 50% greater than Con values. The elevated levels reached at the end of rhIL-6 infusion persisted at least 3 h postinfusion. Triacylglycerol concentrations were unchanged during rhIL-6 infusion, whereas whole body fat oxidation increased after the second hour of rhIL-6 infusion. Of note, during Low-rhIL6, the induced elevation in FA concentration and FA Ra occurred in the absence of any change in adrenaline, insulin, or glucagon, and no adverse side effects were observed. In conclusion, the data identify IL-6 as a potent modulator of fat metabolism in humans, increasing fat oxidation and FA reesterification without causing hypertriacylglyceridemia.
Subject Signal Transduction
DOI - identifier 10.1210/jc.2002-021687
Copyright notice © 2003 The Endocrine Society
ISSN 0021-972X
Versions
Version Filter Type
Citation counts: Scopus Citation Count Cited 373 times in Scopus Article | Citations
Altmetric details:
Access Statistics: 136 Abstract Views  -  Detailed Statistics
Created: Fri, 07 Jan 2011, 09:11:00 EST by Catalyst Administrator
© 2014 RMIT Research Repository • Powered by Fez SoftwareContact us